BMS 150 mg 3624 Pill - blue capsule/oblong, 19mm
Generic Name: atazanavir
Pill with imprint BMS 150 mg 3624 is Blue, Capsule/Oblong and has been identified as Reyataz 150 mg. It is supplied by Bristol-Myers Squibb.
Reyataz is used in the treatment of Nonoccupational Exposure; HIV Infection and belongs to the drug class protease inhibitors. There is no proven risk in humans during pregnancy. Reyataz 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for BMS 150 mg 3624
Reyataz
- Generic Name
- atazanavir
- Imprint
- BMS 150 mg 3624
- Strength
- 150 mg
- Color
- Blue
- Size
- 19.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Protease inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Bristol-Myers Squibb
- Inactive Ingredients
-
lactose monohydrate,
magnesium stearate,
FD&C Blue No. 2,
titanium dioxide,
ferric oxide red,
ferric oxide yellow,
isopropyl alcohol,
ammonia,
propylene glycol,
butyl alcohol,
alcohol,
ferrosoferric oxide,
shellac
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00003-3624 (Discontinued) | |
| 35356-0068 (Discontinued) | Lake Erie Medical and Surgical Supply (repackager) |
Related images for "BMS 150 mg 3624"
More about Reyataz (atazanavir)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (4)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- Drug class: protease inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
